JPS6415659A - Method for measuring human placental alkali phosphatase - Google Patents

Method for measuring human placental alkali phosphatase

Info

Publication number
JPS6415659A
JPS6415659A JP17167587A JP17167587A JPS6415659A JP S6415659 A JPS6415659 A JP S6415659A JP 17167587 A JP17167587 A JP 17167587A JP 17167587 A JP17167587 A JP 17167587A JP S6415659 A JPS6415659 A JP S6415659A
Authority
JP
Japan
Prior art keywords
antibody
alkali phosphatase
human placental
confirming
placental
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP17167587A
Other languages
Japanese (ja)
Inventor
Shunichi Aitsu
Norio Hagi
Kuniyo Inoue
Tsutomu Honjo
Masahiro Shoji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga and Co Ltd
Tosoh Corp
Original Assignee
Morinaga and Co Ltd
Tosoh Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga and Co Ltd, Tosoh Corp filed Critical Morinaga and Co Ltd
Priority to JP17167587A priority Critical patent/JPS6415659A/en
Publication of JPS6415659A publication Critical patent/JPS6415659A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To accurately confirm human placental alkali phosphatase with high sensitivity, by using the first immobilized antibody confirming human placental alkali phosphatase and the second labeled antibody different from said first antibody and confirming an antigen region. CONSTITUTION:The first immobilized antibody confirming human placental alkali phosphatase and the second antibody different from the first antibody and confirming at least an antigen region and labeled with a labeling agent are used. As the antibody, a monoclonal antibody or a polyclonal antibody is used. By confirming human placental alkali phosphatase by a sandwich method or solid phase enzymatic immunoassay using said antibodies, measurement is performed with high sensitivity without receiving the effect of isozyme derived from the tissue other than the placental.
JP17167587A 1987-07-09 1987-07-09 Method for measuring human placental alkali phosphatase Pending JPS6415659A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17167587A JPS6415659A (en) 1987-07-09 1987-07-09 Method for measuring human placental alkali phosphatase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17167587A JPS6415659A (en) 1987-07-09 1987-07-09 Method for measuring human placental alkali phosphatase

Publications (1)

Publication Number Publication Date
JPS6415659A true JPS6415659A (en) 1989-01-19

Family

ID=15927611

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17167587A Pending JPS6415659A (en) 1987-07-09 1987-07-09 Method for measuring human placental alkali phosphatase

Country Status (1)

Country Link
JP (1) JPS6415659A (en)

Similar Documents

Publication Publication Date Title
NO841023L (en) MONOCLONAL ANTIBODIES SPECIFIC ABOVE CROSS-BONDED FIBRIN DERIVATIVES AND PROCEDURE FOR THE DETECTION OF THESE DERIVATIVES
IL58054A (en) Immonological determination of an immuno-complex and diagnostic agent therefor
DK212986D0 (en) PROCEDURE FOR DETERMINING A SUBSTANCE IN A TEST
SI1232392T1 (en) Improved method for the detection of acid resistant bacteria of the genus helicobacter in stool
ATE57018T1 (en) MULTISITE IMMUNOMETRIC TEST PROCEDURE.
AU2790989A (en) Method to produce immunodiagnostic reagents
AU8317482A (en) Assay of antibodies to soluble antigens
ATE74662T1 (en) CHOLESTEROLEPOXIDE IMMUNOANALYTIC TEST PROCEDURE.
NO843591L (en) PROCEDURE FOR AA DETERMINING PIVKA-II CONTENTS IN BLOOD PLASMA AND METHOD FOR EXECUTING THIS
EP0230934A3 (en) Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor.
EP0585960A3 (en) Diagnostic method for autoimmune diseases
EP0303229A3 (en) Method of high sensitivity immunoassay
EP0315447A3 (en) Method of immunological measurement of human protein s and reagent and kit therefor
Takahashi et al. Immunocytochemical characterization of S-100β-positive human T-lymphocytes by a double immunostaining method
JPS57192867A (en) Enzyme immunoassay method of clenbuterol and its analog
ES8601309A1 (en) Method of measuring biological ligands.
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
EP0141616A3 (en) Hybrid cell lines producing monoclonal antibodies directed against trichomonas vaginalis determinants
SE9602234D0 (en) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
JPS55152458A (en) Method of eliminating immunoreaction interference in immunological measurement method
JPS6416964A (en) Method for immunoassay of specific saccharogenic protein
NO165128C (en) PROCEDURE FOR ELIMINATING FALSE POSITIVE RESULTS FROM SYSTEMIC LUPUSERYTHEMATODES PATIENTS IN DETERMINING AN ATL VIRUS ANTIBODY IN A TEST TEST.
ES8802545A1 (en) Method for determining human prolyl 4-hydroxylase by immunoassay.
EP0248147A3 (en) Method of determining the presence of cancer cells
SE8705137D0 (en) DIAGNOSTIC METHOD FOR PRIMARY BILIARY CIRRHOSIS AND ANTIBODIES SUITABLE TO BE USED IN CERTAIN VERSIONS OF THE METHOD